Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-014910

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David Moore
Officer — Chief Commercial Officer
Period of report
Feb 23, 2017
Accepted (ET)
Feb 27, 2017 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———1,500D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F1$3.15Feb 23, 2017A25,000A—Feb 22, 2027Common Stock25,00025,000D
Restricted Stock UnitsF2,F3—Feb 23, 2017A25,000A——Common Stock25,00025,000D
Employee Stock Option (Right to Buy)F4$23.51holding————Dec 31, 2024Common Stock36,36336,363D
Employee Stock Option (Right to Buy)F5$12.79holding————Jan 1, 2024Common Stock100,000100,000D
Employee Stock Option (Right to Buy)F6$31.13holding————Dec 31, 2025Common Stock59,66059,660D
Employee Stock Option (Right to Buy)F7$3.00holding————Jan 2, 2027Common Stock125,000125,000D
Restricted Stock UnitsF2,F3—holding—————Common Stock50,00050,000D

Explanation of responses